•
Jun 30, 2022

Stoke Therapeutics Q2 2022 Earnings Report

Total Revenue
$3.23M
EPS
-$0.63
Previous year: -$0.6
+5.0%
Gross Profit
$2.4M
Cash and Equivalents
$67.8M
Previous year: $169M
-59.9%
Free Cash Flow
-$20.6M
Previous year: -$16.4M
+26.0%
Total Assets
$301M
Previous year: $264M
+14.0%

Stoke Therapeutics

Stoke Therapeutics